Posts Tagged ‘HIV/AIDS’

Liz
Bryan

Spectrum Infection: The U.S. Global Health Initiative: How Can they Measure Results to Create More Success?

Friday, April 16th, 2010
The U.S. Global Health Initiative: Issues and Perspectives Panel

The U.S. Global Health Initiative: Issues and Perspectives Panel

One year ago this May, President Obama announced the formation of the Global Health Initiative (GHI), a $63 billion project spanning six years dedicated to developing a comprehensive U. S global health strategy. With a focus on combating HIV/AIDS, tuberculosis (TB), malaria and other global health issues, the GHI brings together multiple government agencies to strengthen health systems and fight diseases around the world.

Earlier this week I attended a panel discussion and forum organized by The Henry J. Kaiser Family Foundation in which three senior-level government officials involved in the GHI addressed key issues ranging from implementation challenges to promoting country ownership of GHI initiatives, to budget allocations, to the GHI’s increased focus on women’s health issues.

As the panel spoke and answered audience questions, one theme caught my attention again and again: the need for the GHI to better measure and capitalize on their successes, apply them to existing and expanded platforms and push for results. (more…)

Tags: , , , , , , ,

 
Infectious
Disease

Spectrum Infection Thursday: Shining a Spotlight on Malaria – Part II

Thursday, April 1st, 2010

I’ve been thinking for the last few days about a blog post that Brennan Gamwell, one of our interns, wrote last week on the Full Spectrum Blog. He wrote, “An estimated 250 million people are infected with malaria each year, and nearly one million die. The toll of the disease is most notable in Sub-Saharan Africa, where between two and four percent of individuals are infected, and where the mortality rate climbs even higher due to a substantial number of co-infections with HIV/AIDS.”

I wanted to expand on that because it contains an interesting fact, and leaves us with something to ponder. And that is, if we could improve prevention, diagnosis and treatment of TB and malaria, some estimate that we could potentially reduce the number of people dying with AIDS by about half. In 2008, two million people died with AIDS. That means that about two million people who died in 2008 and 2009 would be alive today, including many children in the developing world. 

TB and malaria are both preventable and curable conditions, and we have made enormous strides in malaria prevention and treatment. But much more needs to be done. ONE, the global grassroots advocacy organization characterizes the challenge: ”While the world has battled malaria and TB for centuries, the immense human toll of AIDS in the late 1990s injected a new urgency into the need to enhance prevention and treatment efforts. Though the resources to fight these diseases have increased exponentially in recent years, funding remains too little and too slow in coming. Moreover, weak health systems have limited success in the fight against these diseases, especially in sub-Saharan Africa.” (more…)

Tags: , , , , , , ,

 
Erica
Anderson

Pre-Existing America

Friday, September 25th, 2009

In 2002, seven years before the current health care reform debate consumed America, 17-year-old Jerome Mitchell made the news when his insurance policy was revoked based on a pre-existing condition cited by the insurance company: HIV.

Today, with our nation in the throes of a high stakes and often emotional health care debate, Mitchell’s story once again makes the news.

Seven years after it first caught our attention, his story now burns anew in the blogosphere, on discussion boards, in the Huffington Post, on the homepage of DIGG – reignited by a Sept. 16 South Carolina Supreme Court decision that ordered Fortis Insurance Company, now operating as Assurant Health, to pay Mitchell $10 million in damages for abandoning him when he needed it the most. (more…)

Tags: , ,

 
Michael
Cover

This Morning We Discovered Hope

Thursday, September 24th, 2009

This morning I woke up to news I have been waiting to hear for more than 20 years.  Researchers have finally developed a preventive vaccine against HIV that showed modest efficacy.  For every 100 people that would have become infected if they had not received the vaccine, 32 infections were prevented.  This level of efficacy (32%) is modest, and too low to proceed to license the vaccine.  However, the results are significant.  They will give a real boost to the field and provide a base on which they can improve.

While this is absolutely reason to celebrate a remarkable scientific achievement, we should note a couple of important things:

First, the vaccine was only studied with the type of HIV commonly found in Thailand.  More research will have to be done to discover whether similar results can be shown in Africa and North and South American strains.

Second, researchers also wanted to discover if the vaccine had any effect on reducing the amount of virus in the blood of volunteers who seroconverted during the trial.  Sadly, it did not have any therapeutic benefits.

Still, this is a clear victory that gives researchers, and all of us who care about ending AIDS, one thing that has been in short supply:  hope that we will be the generation that ends AIDS through the discovery of a preventive vaccine.

Tags: , ,